RxDoctor Payments Data

Patricia Chamul

Physician Assistant · Los Angeles, CANPI 1619287869

Payments from drug & device makers

$911in general payments, 2019–2025

Across 40 payments — averaging $22.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$317
  • Bayer$133
  • Novo Nordisk$76
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$66
  • Boehringer Ingelheim$55
  • Abbott$48
  • plus $215 from 9 others

What the payments were for

  • Food & beverage$911100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$911 in reported general payments places this provider in the 70th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$23,327
Medicare patients
89
Services billed
407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin42$37,492
OzempicSemaglutide25$22,576
JanuviaSitagliptin Phosphate17$19,987
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog42$19,859
EliquisApixaban25$18,164
TrulicityDulaglutide12$15,840
TradjentaLinagliptin11$11,521
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$3,997
Albuterol Sulfate HfaAlbuterol Sulfate91$3,066
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm19$2,441
Solifenacin Succinate14$1,478
Wixela InhubFluticasone Propion/Salmeterol11$1,301
Atorvastatin Calcium210$1,219
Levothyroxine Sodium57$901
Azelastine Hcl37$744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$55$49,01353 claims
Novo NordiskOzempic$76$22,57625 claims
MerckJanuvia$20$19,98717 claims
Lilly USA, LLCTrulicity$317$15,84012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →